Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA394319
Max Phase: Preclinical
Molecular Formula: C13H18FNO3
Molecular Weight: 255.29
Molecule Type: Small molecule
Associated Items:
ID: ALA394319
Max Phase: Preclinical
Molecular Formula: C13H18FNO3
Molecular Weight: 255.29
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(CC(N)C(=O)O)cc1CCC[18F]
Standard InChI: InChI=1S/C13H18FNO3/c1-18-12-5-4-9(8-11(15)13(16)17)7-10(12)3-2-6-14/h4-5,7,11H,2-3,6,8,15H2,1H3,(H,16,17)/i14-1
Standard InChI Key: RZVBRZHTDSVYNE-UMSOTBISSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 255.29 | Molecular Weight (Monoisotopic): 255.1271 | AlogP: 1.55 | #Rotatable Bonds: 7 |
Polar Surface Area: 72.55 | Molecular Species: ZWITTERION | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 2.41 | CX Basic pKa: 9.47 | CX LogP: -0.49 | CX LogD: -0.49 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.78 | Np Likeness Score: 0.35 |
1. Moon BS, Lee TS, Lee KC, An GI, Cheon GJ, Lim SM, Choi CW, Chi DY, Chun KS.. (2007) Syntheses of F-18 labeled fluoroalkyltyrosine derivatives and their biological evaluation in rat bearing 9L tumor., 17 (1): [PMID:17035015] [10.1016/j.bmcl.2006.09.063] |
Source(1):